全文获取类型
收费全文 | 11916篇 |
免费 | 581篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 338篇 |
儿科学 | 465篇 |
妇产科学 | 593篇 |
基础医学 | 1083篇 |
口腔科学 | 286篇 |
临床医学 | 845篇 |
内科学 | 2357篇 |
皮肤病学 | 389篇 |
神经病学 | 661篇 |
特种医学 | 763篇 |
外国民族医学 | 1篇 |
外科学 | 2693篇 |
综合类 | 106篇 |
一般理论 | 9篇 |
预防医学 | 582篇 |
眼科学 | 340篇 |
药学 | 399篇 |
中国医学 | 2篇 |
肿瘤学 | 600篇 |
出版年
2021年 | 94篇 |
2020年 | 63篇 |
2019年 | 88篇 |
2018年 | 122篇 |
2017年 | 91篇 |
2016年 | 112篇 |
2015年 | 608篇 |
2014年 | 712篇 |
2013年 | 741篇 |
2012年 | 839篇 |
2011年 | 759篇 |
2010年 | 759篇 |
2009年 | 695篇 |
2008年 | 783篇 |
2007年 | 713篇 |
2006年 | 690篇 |
2005年 | 615篇 |
2004年 | 454篇 |
2003年 | 253篇 |
2002年 | 207篇 |
2001年 | 187篇 |
2000年 | 185篇 |
1999年 | 206篇 |
1998年 | 91篇 |
1997年 | 92篇 |
1996年 | 100篇 |
1995年 | 89篇 |
1994年 | 69篇 |
1993年 | 71篇 |
1992年 | 107篇 |
1991年 | 104篇 |
1990年 | 115篇 |
1989年 | 118篇 |
1988年 | 113篇 |
1987年 | 102篇 |
1986年 | 111篇 |
1985年 | 112篇 |
1984年 | 83篇 |
1983年 | 98篇 |
1982年 | 54篇 |
1981年 | 64篇 |
1980年 | 53篇 |
1979年 | 82篇 |
1978年 | 50篇 |
1977年 | 49篇 |
1976年 | 45篇 |
1974年 | 71篇 |
1973年 | 55篇 |
1972年 | 48篇 |
1966年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Sibylle M. Winter Katja Dittrich Peggy Dörr Judith Overfeld Imke Moebus Elena Murray Gergana Karaboycheva Christian Zimmermann Andrea Knop Manuel Voelkle Sonja Entringer Claudia Buss John-Dylan Haynes Elisabeth B. Binder Christine Heim 《Journal of child psychology and psychiatry, and allied disciplines》2022,63(9):1027-1045
2.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
3.
Qingyang Xiao Yitian Zhou Stefan Winter Florian Büttner Elke Schaeffeler Matthias Schwab Volker M. Lauschke 《International journal of cancer. Journal international du cancer》2020,146(9):2475-2487
Multidrug resistance due to facilitated drug efflux mediated by ATP-binding cassette (ABC) transporters is a main cause for failure of cancer therapy. Genetic polymorphisms in ABC genes affect the disposition of chemotherapeutics and constitute important biomarkers for therapeutic response and toxicity. Here we correlated germline variability in ABC transporters with disease-specific survival (DSS) in 960 breast cancer (BRCA), 314 clear cell renal cell carcinoma and 325 hepatocellular carcinoma patients. We find that variant burden in ABCC1 is a strong predictor of DSS in BRCA patients, whereas candidate polymorphisms are not associated with DSS. This association is highly drug-specific for subgroups treated with the MRP1 substrates cyclophosphamide (log-rank p = 0.0011) and doxorubicin (log-rank p = 0.0088) independent of age and tumor stage, whereas no association was found in individuals treated with tamoxifen (log-rank p = 0.13). Structural mapping of significant variants revealed multiple variants at residues involved in protein stability, cofactor stabilization or substrate binding. Our results demonstrate that BRCA patients with high variant burden in ABCC1 are less prone to respond appropriately to pharmacological therapy with MRP1 substrates, thus incentivizing the consideration of genomic germline data for precision cancer medicine. 相似文献
4.
Yang Lin Wu Hui de Winter Brenda C. M. Sheng Chang-cheng Qiu Hong-qiang Cheng Yu Chen Juan Zhao Qiu-ling Huang Jing Jiao Zheng Xie Rui-xiang 《Cancer chemotherapy and pharmacology》2020,85(5):881-897
Cancer Chemotherapy and Pharmacology - High-dose methotrexate (HD-MTX) is widely used in the treatment of non-Hodgkin lymphoma (NHL), but the pharmacokinetic properties of HD-MTX in Chinese adult... 相似文献
5.
6.
7.
8.
9.
10.